Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06636383 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Minor2 versionsRe-verified since Feb 3, 2026, no change to tracked fieldsv17-v18
Show 15 earlier versionsHide 15 earlier versions
MinorSite details revised at 1 of 19 sitesv16
MinorSite details revised at 1 of 19 sitesv15
MinorSite details revised at 3 of 19 sitesv14
MinorRe-verified, no change to tracked fieldsv13
MinorSite details revised at 2 of 19 sitesv12
MinorSite details revised at 1 of 19 sitesv11
MinorSite details revised at 1 of 19 sitesv10
MinorSite details revised at 2 of 19 sitesv9
MinorRe-verified, no change to tracked fieldsv8
MinorSite details revised at 1 of 19 sitesv7
MinorRe-verified, no change to tracked fieldsv6
MinorStudy sites: 20 to 19v5
MinorStudy sites: 18 to 20v4
MinorRe-verified, no change to tracked fieldsv3
NotableTrial status: Not Yet Recruiting to RecruitingStart date changed from estimate of Oct 2024 to Nov 4, 2024 · Site details revised at 18 of 18 sitesv2Show 2 more changesShow less
Start date changed from estimate of Oct 2024 to Nov 4, 2024
Site details revised at 18 of 18 sites
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objective of this observational study is to evaluate the long-term safety and effectiveness of DTX401 for at least 10 years after DTX401 administration.